300+ investors in your industry, stage, and region Get
Any industry
Hospitality
Video Games
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
Energy
SaaS
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Wellness
Education
Medical Device
Automotive
eSports
Sports
Legal
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Medical
Web3
Theatre
Recruiting
Crowdfunding
Infrastructure
Venture Capital
Beauty
Fashion
Social
Celebrity
LGBT
Climate
Cannabis
Wine and Spirits
Mobile Apps
Life Science
Food and Beverage
Publishing
Art
Music
Real Estate
Sporting Goods
FinTech
Finance
Digital Media
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Sustainability
Proptech
Hardware
Impact
Transportation
Biotech
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
Japan
South Korea
Singapore
Burkina Faso
LATAM
Brazil
Africa
Gibraltar
Egypt
Oceania
Taiwan
Zimbabwe
Tunisia
Sweden
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Kyrgyzstan
Haiti
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Oman
Puerto Rico
Poland
Colombia
Guernsey
Cameroon
China
Armenia
Marshall Islands
Costa Rica
Czech Republic
Kuwait
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Jamaica
Sri Lanka
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Uganda
Myanmar
Turkey
Uruguay
Morocco
Botswana
Moldova
Seychelles
Paraguay
South Africa
France
Denmark
Georgia
Ghana
Iraq
Portugal
Philippines
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Angola
Europe
Cyprus
Spain
Qatar
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Faroe Islands
Estonia
Bahrain
Bahamas
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Iceland
Lithuania
Cambodia
Liechtenstein
Lebanon
Mongolia
Slovenia
Peru
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
IBK Capital, VC Fund

IBK Capital

VC Fund

Toronto, Canada

IBK Capital is an independent and privately owned investment banking firm which offers a full range of financial advisory services. Such services include private placements of equity and debt, going public by way of reverse take-over, merger, acquisition and divestiture advisory services, valuations, fairness opinions and take-over defenceplanning. The Firm’s corporate objective is to provide the highest quality independent financial advisory services to its clients.IBK Capital was founded by a group of experienced professionals who had previously worked for many years as investment bankers with Merrill Lynch Canada Inc. Since its inception in February 1989, IBK Capital has established an enviable track record as an independent Canadian financial advisory firm, having played a role in transactions with a combined value of $5.6 billion. IBK Capital has successfully completed numerous financial advisory engagements including capital raising assignments for a large number of companies, globally. The Team is proud of its expertise and has a solid track record in the Canadian investment banking community.Companies serviced by IBK Capital are active in the MINING SECTOR (precious metals, base metals, precious gems, industrial minerals, coal and uranium), the RENEWABLE ENERGY SECTOR (solar, wind and bio fuels such as peat) and the TECHNOLOGY SECTOR (semiconductors, telecommunications, environmental sciences and animation).

Total investments:
26
Last investment:
Lead investor:
4%

Last updated:

Industries IBK Capital invests in

BiotechnologyHealth CareGamingRentalTravel

Stages IBK Capital invests in

Series ASeries BSeedSeries CFunding Round

Countries IBK Capital invests in

South KoreaUnited Kingdom

Round sizes

Seed $752k–$1.3MSeries A $1.2M–$18MSeries B $3.9M–$26M

Contacts

NameEmailPhoneSocials

Sign up to unlock verified contacts

Unlock Contacts

Round size

Seed
$752k–$1.3M
Series A
$1.2M–$18M
Series B
$3.9M–$26M

Investment Focus

Industry

  • Biotechnology 5 (19%)
  • Health Care 4 (15%)
  • Gaming 2 (8%)
  • Rental 2 (8%)
  • Travel 2 (8%)
See all 49 industries →

Stage

  • Series A 10 (38%)
  • Series B 6 (23%)
  • Seed 4 (15%)
  • Series C 2 (8%)
  • Funding Round 2 (8%)
See all 7 stages →

Country

  • South Korea 21 (81%)
  • United Kingdom 1 (4%)

Team

NameTitleInvestmentsLinksEmail
Michael White
Michael White President and Chief Executive Officer
President and Chief Executive Officer Total investments: 0
Find email
William F. White
William F. White Founder and Chairman
Founder and Chairman Total investments: 0 Find email

Investments

CompanyDescriptionRoundLinks
HJ Wave is a manufacturing comapny that designs and develops millimeter-wave RF band, including radar antennas for autonomous driving. $23K / Dec 03, 2024
HJ Wave is a manufacturing comapny that designs and develops millimeter-wave RF band, including radar antennas for autonomous driving. $31.8M / Series A / Dec 03, 2024
SeaVantage offers real-time info & AI-based predictions for stakeholders across the maritime logistics industry. $1.2M / Dec 30, 2022
SeaVantage offers real-time info & AI-based predictions for stakeholders across the maritime logistics industry. $1.2M / Series A / Dec 28, 2022
SeaVantage offers real-time info & AI-based predictions for stakeholders across the maritime logistics industry. $1.3M / Seed / Dec 28, 2022
MetaFines is a biopharma firm that creates anticancer medications with the goal of preventing the spread of cancer. By extending and reconfiguring the indications of off-label medications for terminal tumors, the company creates minimal anticancer pharmaceuticals. It also provides subcutaneous injections and therapies, allowing patients to fightcancer and enhance their standard of living with cancer metabolism.The company develops ow-toxic medicines for metabolic cancer. This low-toxic metabolic anti-cancer agent is distinguished by being created so that metabolic anti-cancer agents that limit cell growth but operate via various pathways can work in concert with one another. $15.7M / Series B / Apr 28, 2022
GGQ GGQ
GGQ platform helps gamers with in-depth personalization and reports to maximize potential. $9M / Series A / Apr 13, 2022
Ronfic develops a smart fitness healthcare system. $3.4M / Series A / Jan 18, 2022
Mthera Pharma is a biopharmaceutical research and development company. Series B / Dec 24, 2021
Habipool operates as an online hobby class service. $3.5M / Series A / Oct 27, 2021
See all 26 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Hospitality
Video Games
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
Energy
SaaS
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Wellness
Education
Medical Device
Automotive
eSports
Sports
Legal
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Medical
Web3
Theatre
Recruiting
Crowdfunding
Infrastructure
Venture Capital
Beauty
Fashion
Social
Celebrity
LGBT
Climate
Cannabis
Wine and Spirits
Mobile Apps
Life Science
Food and Beverage
Publishing
Art
Music
Real Estate
Sporting Goods
FinTech
Finance
Digital Media
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Sustainability
Proptech
Hardware
Impact
Transportation
Biotech
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
Japan
South Korea
Singapore
Burkina Faso
LATAM
Brazil
Africa
Gibraltar
Egypt
Oceania
Taiwan
Zimbabwe
Tunisia
Sweden
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Kyrgyzstan
Haiti
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Oman
Puerto Rico
Poland
Colombia
Guernsey
Cameroon
China
Armenia
Marshall Islands
Costa Rica
Czech Republic
Kuwait
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Jamaica
Sri Lanka
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Uganda
Myanmar
Turkey
Uruguay
Morocco
Botswana
Moldova
Seychelles
Paraguay
South Africa
France
Denmark
Georgia
Ghana
Iraq
Portugal
Philippines
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Angola
Europe
Cyprus
Spain
Qatar
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Faroe Islands
Estonia
Bahrain
Bahamas
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Iceland
Lithuania
Cambodia
Liechtenstein
Lebanon
Mongolia
Slovenia
Peru
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does IBK Capital invest in?

IBK Capital invests primarily in Biotechnology, Health Care and Gaming startups, most often at Series A and Series B stage. Most of the 26 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What round sizes does IBK Capital invest in?

IBK Capital typically joins rounds of $752k–$1.3M at Seed, $1.2M–$18M at Series A and $3.9M–$26M at Series B. These are whole funding-round sizes, not IBK Capital's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds IBK Capital took part in.

How do I contact IBK Capital?

Public channels for IBK Capital include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at IBK Capital?

The team at IBK Capital includes Michael White (President and Chief Executive Officer) and William F. White (Founder and Chairman). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
IBK Capital IBK Capital Find emails